Search Results - "Kirchweger, P"

Lost gallstones during laparoscopic cholecystectomy as a common but underestimated complication-case report and review of the literature by Danhel, L, Fritz, A, Havranek, L, Kratzer, T, Punkenhofer, P, Punzengruber, A, Rezaie, D, Tatalovic, S, Wurm, M, Függer, R, Biebl, M, Kirchweger, P

“…Laparoscopic cholecystectomy (LC) represents one of the most commonly performed routine abdominal surgeries. Nevertheless, besides bile duct injury, problems…”
Get full text

Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivity by Mavroeidi, I.-A., Burghofer, J., Kalbourtzis, S., Taghizadeh, H., Webersinke, G., Piringer, G., Kasper, S., Schreil, G., Liffers, S.T., Reichinger, A., Kirchweger, P., Heibl, S., Hamacher, R., Schmitt, C.A., Schuler, M., Prager, G.W., Kersting, D., Treckmann, J., Schildhaus, H.-U., Rumpold, H., Siveke, J.T., Doleschal, B.

“…Biliary tract cancers (BTCs) exhibit high mortality rates and significant heterogeneity in both clinical and molecular characteristics. This study aims to…”
Get full text

Bevacizumab mitigates codon specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer by Doleschal, Bernhard, Taghizadeh, Hossein, Lentner, Theresa, Riedl, Jakob M., Granitzer, Janine, Morariu, Darius, Decker, Jörn, Aichberger, Karl J., Webersinke, Gerald, Kirchweger, Patrick, Petzer, Andreas, Rumpold, Holger

“…Molecular informed therapy changed treatment patterns of metastatic colorectal cancer. Recently KRAS G12, the most prevalent RAS mutation in mCRC, was…”
Get full text

Circulating tumor DNA (CtDNA) as clinical applicable biomarker for neoadjuvant chemotherapy vs. surgery in localized pancreatic cancer by Kirchweger, P.

Get full text

12P Circulating tumor DNA as early marker of response to treatment in stage IV gastrointestinal cancer by Kirchweger, P., Kupferthaler, A., Burghofer, J., Webersinke, G., Jukic, E., Schwendinger, S., Függer, R., Biebl, M., Wundsam, H., Rumpold, H.

Get full text

506P Relation of metastasis localization, survival outcome and treatment modality in metastatic colorectal cancer by Kirchweger, P., Wundsam, H., Niedersüß-Beke, D., Thaler, J., Rumpold, H.

Get full text

Hepatic Resections Performed in Intermediate- to High-volume Centres in Austria – A Pilot Study of the Austrian Association of Hepato-pancreato-Biliary Surgery (AAHPBS) by Dong, Y., Primavesi, F., Wagner, D., Kornprat, P., Hoblaj, T., Kirchweger, P., Wundsam, H., Braunwarth, E., Schneeberger, S., Biebl, M., Sucher, R., Staettner, S., Gruenberger, T.

Get full text

Histone citrullination as a novel biomarker and target to inhibit progression of abdominal aortic aneurysms by Eilenberg, Wolf, Zagrapan, Branislav, Bleichert, Sonja, Ibrahim, Nahla, Knöbl, Viktoria, Brandau, Annika, Martelanz, Luca, Grasl, Marie-Therese, Hayden, Hubert, Nawrozi, Paimann, Rajic, Renata, Häusler, Charlotte, Potolidis, Alexandros, Schirwani, Nawa, Scheuba, Andreas, Klopf, Johannes, Teubenbacher, Peter, Weigl, Markus P., Kirchweger, Patrick, Beitzke, Dietrich, Stiglbauer-Tscholakoff, Alexander, Panzenböck, Adelheid, Lang, Irene, Mauracher, Lisa-Marie, Hell, Lena, Pabinger, Ingrid, Bailey, Marc A., Scott, D. Julian A., Maegdefessel, Lars, Busch, Albert, Huk, Ihor, Neumayer, Christoph, Brostjan, Christine

“…Neutrophil extracellular traps (NETs) have been implicated in the pathogenesis of abdominal aortic aneurysms (AAAs). This study has addressed the notion that…”
Get full text

Design of an allosterically modulated doxycycline and doxorubicin drug-binding protein by Schmidt, Karin, Gardill, Bernd R., Kern, Alina, Kirchweger, Peter, Börsch, Michael, Muller, Yves A.

“…The allosteric interplay between distant functional sites present in a single protein provides for one of the most important regulatory mechanisms in…”
Get full text

89P ctDNA as an unifiable biomarker to predict response to treatment after 2 weeks of chemotherapy at the same cut-off for metastatic GEC, PC and CRC by Kirchweger, P., Doleschal, B., Kupferthaler, A., Burghofer, J., Webersinke, G., Schwendinger, S., Ennemoser, A., Jukic, E., Petzer, A.L., Rumpold, H.

Get full text

76P Prediction of response to palliative chemotherapy by circulating tumor DNA (ctDNA) kinetics in metastatic pancreatic cancer by Kirchweger, P., Kupferthaler, A., Burghofer, J., Webersinke, G., Jukic, E., Schwendinger, S., Wundsam, H., Biebl, M., Petzer, A.L., Rumpold, H.

Get full text

88P Circulating tumor DNA (ctDNA) as precision medicine marker for neoadjuvant chemotherapy vs upfront surgery in primary resectable localized pancreatic cancer by Kirchweger, P., Doleschal, B., Kupferthaler, A., Burghofer, J., Webersinke, G., Schwendinger, S., Ennemoser, A., Jukic, E., Wundsam, H., Biebl, M., Rumpold, H.

Get full text

P361Histone citrullination of neutrophil extracellular traps is a novel biomarker and target to inhibit progression of abdominal aortic aneurysms by Eilenberg, W, Zagrapan, B, Martelanz, L, Grasl, M T, Potolidis, A, Nawrozi, P, Kirchweger, P, Huk, I, Neumayer, C, Brostjan, C

Get full text

P176An improved diagnostic score for abdominal aortic aneurysms based on a comprehensive analysis of myeloid cell parameters by Zagrapan, B, Eilenberg, W, Muench, K, Rajic, R, Kirchweger, P, Jilma, B, Huk, I, Heinze, G, Neumayer, C H, Brostjan, C H

Get full text

Treatment of drug-induced agranulocytosis with recombinant granulocyte colony-stimulating factor (rh G-CSF) by WILLFORT, A, LORBER, C, KAPIOTIS, S, SERTL, S, HAINZ, R, KIRCHWEGER, P, JÄGER, U, KYRLE, P. A, LECHNER, K, GEISSLER, K

“…Five patients with drug-induced agranulocytosis received 300 micrograms recombinant human granulocyte colony-stimulating factor (rh G-CSF) subcutaneously twice…”
Get full text